Craig A. Collard - 22 Aug 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig Collard
Issuer symbol
HRTX
Transactions as of
22 Aug 2023
Net transactions value
-$1,142
Form type
4
Filing time
24 Aug 2023, 16:09:50 UTC
Previous filing
26 Jun 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Tax liability $1,142 -692 -1.9% $1.65 36,496 22 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to the quarterly vesting of shares from the restricted stock grant made on February 22, 2023.